SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences informs about newspaper publication

09 Jul 2025 Evaluate

Nectar Lifesciences has informed that it enclosed a newspaper copy of Publication of Financial Results of the Company for the quarter and financial year ended on March 31, 2025, which have been published in the newspapers, Business Standard (English-all editions) dated 09.07.2025 - circulating in the whole or substantially the whole of India and Desh Sewak (Punjabi) dated 09.07.2025 being published in language of the region where the registered office of the Company is situated.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

12.26 0.32 (2.68%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×